JT
CLBT icon

Jupiter Topco’s Cellebrite CLBT Stock Holding History

Jupiter Topco’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Buy
+926,155
New +$12.2M 0.01% 741

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Topco's CLBT Position: Q2 2026 in Review

Jupiter Topco opened a new position in Cellebrite (CLBT) in Q2 2026: 926,155 shares worth $13.5M. The stake represents 0.01% of the portfolio and ranks #741 among its holdings.

186 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jupiter Topco held 926,155 shares of Cellebrite worth $13.5M as of Q2 2026.
  • Cellebrite was a new Jupiter Topco position in Q2 2026.
  • Cellebrite made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #741 holding.
  • 186 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.